Peter M. L. Teo

2.5k total citations · 1 hit paper
25 papers, 1.7k citations indexed

About

Peter M. L. Teo is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, Peter M. L. Teo has authored 25 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Otorhinolaryngology, 16 papers in Surgery and 14 papers in Oncology. Recurrent topics in Peter M. L. Teo's work include Head and Neck Cancer Studies (19 papers), Head and Neck Surgical Oncology (9 papers) and Viral-associated cancers and disorders (5 papers). Peter M. L. Teo is often cited by papers focused on Head and Neck Cancer Studies (19 papers), Head and Neck Surgical Oncology (9 papers) and Viral-associated cancers and disorders (5 papers). Peter M. L. Teo collaborates with scholars based in China, Hong Kong and United Kingdom. Peter M. L. Teo's co-authors include Philip J. Johnson, Anthony T.�C. Chan, S. F. Leung, W. H. Kwan, W.M. Sze, Benny Zee, Stewart Y. Tung, W.H. Lau, Dora L.�W. Kwong and Daniel T. T. Chua and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Peter M. L. Teo

23 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience

2005 482 citations Anne W.M. Lee, W.M. Sze et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers

Countries citing papers authored by Peter M. L. Teo

Since Specialization

Citations

This map shows the geographic impact of Peter M. L. Teo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. L. Teo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. L. Teo more than expected).

Fields of papers citing papers by Peter M. L. Teo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. L. Teo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. L. Teo. The network helps show where Peter M. L. Teo may publish in the future.

Co-authorship network of co-authors of Peter M. L. Teo

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. L. Teo. A scholar is included among the top collaborators of Peter M. L. Teo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. L. Teo. Peter M. L. Teo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	488P Audit of toxicity and tolerance of DPYD variant patients receiving fluoropyrimidines on effectiveness of recommended dose reductions in reducing toxicity 2024 ·Annals of Oncology ·(unknown), Peter M. L. Teo, (unknown), Sukhdeep Kaur, (unknown), (unknown), (unknown), (unknown), Ian Geh	0
2	Developing an adaptive radiation therapy strategy for nasopharyngeal carcinoma 2013 ·Journal of Radiation Research ·(unknown), V. Wu, Peter M. L. Teo	35
3	Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience breakdown → 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Anne W.M. Lee, W.M. Sze, Joseph S. K. Au, S. F. Leung, To‐Wai Leung, Daniel T. T. Chua, Benny Zee, Stephen C.K. Law, Peter M. L. Teo, Stewart Y. Tung, Dora L.�W. Kwong, W.H. Lau	482
4	Nasopharyngeal Cancer 2004 ·Cancer treatment and research ·Anthony T.�C. Chan, (unknown), Peter M. L. Teo, (unknown), Philip J. Johnson, (unknown)	12
5	Nasopharyngeal carcinoma 2002 ·Annals of Oncology ·Anthony T.�C. Chan, Peter M. L. Teo, Philip J. Johnson	239
6	Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma 2001 ·Radiotherapy and Oncology ·Ricky Ming-chun Chau, Peter M. L. Teo, Peter H.K. Choi, K.Y. Cheung, (unknown)	35
7	The use of brush cytology and directed biopsies for the detection of nasopharyngeal carcinoma and precursor lesions 2001 ·Head & Neck ·Alex R. Chang, (unknown), Anthony T.�C. Chan, (unknown), Peter M. L. Teo, Philip J. Johnson	10
8	Staging computed tomography of the thorax for nasopharyngeal carcinoma 2000 ·Head & Neck ·(unknown), H. T. Andrew Cheung, Peter M. L. Teo, (unknown)	12
9	Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: A twelve-year experience 2000 ·Head & Neck ·Walter King, Peter K. M. Ku, (unknown), Peter M. L. Teo	119
10	Palatal lymphoepitheliomas and a review of head and neck lymphoepitheliomas 1999 ·Clinical Radiology ·Anil T. Ahuja, Peter M. L. Teo, Ka‐Fai To, Ann D. King, C. Metreweli	8
11	The role of chemotherapy in the management of nasopharyngeal carcinoma 1998 ·Cancer ·Anthony T.�C. Chan, Peter M. L. Teo, (unknown), Philip J. Johnson	89
12	Assessment of proliferating cell nuclear antigen in nasopharyngeal carcinoma tissue and its relation to clinical findings 1997 ·Oral Oncology ·Anthony T.�C. Chan, Simone S.M. Ho, Peter M. L. Teo, (unknown), Junjeong Choi, (unknown), Anne B. Chang, W. H. Kwan, Wai K. Leung, P. Johnson	7
13	A comparison of the psychosocial impact of breast conserving therapy and total mastectomy n breast cancer patients and their partners 1997 ·European Journal of Cancer ·Winnie Yeo, W. H. Kwan, Peter M. L. Teo, (unknown), (unknown), (unknown), (unknown)	1
14	Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma 1996 ·Cancer ·Peter M. L. Teo, W. H. Kwan, W. Y. Lee, S. F. Leung, Philip J. Johnson	182
15	A retrospective study of the role of intracavitary brachytherapy and prognotic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients 1996 ·Clinical Oncology ·Peter M. L. Teo, W. H. Kwan, Peter S. Y. Yu, Wang‐Tso Lee, S.W. Leung, Peter Choi	25
16	A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma 1995 ·International Journal of Radiation OncologyBiologyPhysics ·Anthony T.�C. Chan, Peter M. L. Teo, Thomas Leung, Sing Fai Leung, (unknown), Winnie Yeo, Peter H.K. Choi, (unknown)	222
17	Patterns of failure after radical neck dissection for recurrent nasopharyngeal carcinoma 1992 ·The American Journal of Surgery ·Walter King, Peter M. L. Teo, Arthur K.C. Li	10
18	The efficacy of combination cisplatinum, Adriamycin and cyclophosphamide in malignant thymoma 1990 ·International Journal of Clinical Practice ·W. Shiu, Peter M. L. Teo, Kenneth C.W. Wong	7
19	A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong 1989 ·International Journal of Radiation OncologyBiologyPhysics ·Peter M. L. Teo, S.Y. Tsao, (unknown), (unknown), Victor Tsang, Peter S. Y. Yu, Collin M.M. Lui	78
20	Adjunctive chemotherapy to radical radiation therapy in the treatment of advanced nasopharyngeal carcinoma 1987 ·International Journal of Radiation OncologyBiologyPhysics ·Peter M. L. Teo, J. H. C. Ho, Damon Choy, Peter Choi, Ke‐Hung Tsui	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact